Mike Sheikh

Blown away by the @ExousiaBio $LMMY $MAJI Projenicyte JV presentation #REMIJPM How can u not be excited about this potential #GBM treatment going through the regulatory process. Pay attention to the beginning. Replay it a couple of times. Let it sink in. Let’s get some engagement. #JPM2026 #biotechshowcase #Glioblastoma

@DrPatrick says the #COVID19 is an oncogenic virus that causes cancer. Says more evidence is needed but his point is that if #SARSCOV2 isn't cleared it creates a pocket of inflammation while suppressing the immune system. Perfect breeding ground for cancer. This is why we need Broad spectrum antivirals from $BIXT $NNVC. Viruses need to be treated quick & catching colds and letting them persist is not healthy. Its like giving cancer a power play in hockey. Avoid getting sick if you can.

Heartbreaking. 13-year-old with metastatic pancreatic cancer. 10 & 12-year-olds fighting colon cancer. Dr. Patrick Soon-Shiong says “turbo cancer” in kids keeps him up at night. They knew the COVID vaccine was dangerous yet pushed it on children anyway.

I suspect your probably going to attack me because I don’t have MD after my name but before you do know I’m a drug developer with the only clinical trial in the past 14 years w/100% responders rate. That’s out of 15,000 clinical trials. I know what a cure looks like. Follow me and find out. pubmed.ncbi.nlm.nih.gov/37112643/ so maybe I know a thing or two about the immune system. @LoriMills4CA42

The FDA issued a warning letter to ImmunityBio over claims that Anktiva can "cure cancer" and "treat all cancers." There's a lot to unpack here. Today at 3:10 PM PST, @drgoodyear and I are going live to talk about what Anktiva actually is, how we use it at WCI, and why no single drug is the answer. Join us.

It’s not about the person, it’s about the medicine. Personal attacks against his credentials are your right but it’s unfair to stain the science behind the treatment. It seems like that’s your angle so how about the science? #ANKTIVA anktiva.com. Approved cancer drug used off label. Not seeing the issue. Approvals by indication is an archaic remnant of the FDA. If immunotherapy MOA works on one cancer likely to work on all. @LoriMills4CA42 Tell us why patients should be deprived of treatment?

Exciting news for $MAJI: When our site is live! Anyone interested in joining our groundbreaking cancer screening study can now sign up directly online. Once enrolled, you’ll receive a comprehensive at-home collection kit with clear instructions for a seamless return. Your results will be delivered securely via email, and all data is strictly managed under HIPAA guidelines to ensure your privacy. Join us in advancing early detection!..more to come.

ROTH kicked off tonight with a bang. Presentations and networking tomorrow. About 50 healthcare companies at conference. Looking for synergies that make sense.

On my way to ROTH for networking. Some of you found the little Easter Egg I left. Did you know $EXAS has a $20 B market cap. $ILMN $19 B $GH $11 B. Ripe for disruption. There has to be a better way.

@NotTheMoma2 Ever notice the maneuver cost all shareholders 26.5% dilution & only impacted one persons shares. The cost benefit analysis is akin to dropping boulders on shareholders to to find a penny under them. You missed the point your looking at the shiny new object but you got dumped on

Sounds like $BIXT share lock up (Good News) Before good news to me. youtu.be/oR5obxavU8U

$FNGR News on Acquisition. FingerMotion Signs Agreement to Acquire Telforge, Inc finance.yahoo.com/news/fingermot…

$MAJI is shifting into high gear! With 100% of our time and energy now dedicated to scaling the company, our roadmap for the rest of March is packed with transformative milestones.

@buffalofireside @ChaseMacTrades Concerned my largest position in going to need this soon. But yep that's about how I feel. Uugh

@ChaseMacTrades 💯 😆 🤣

OTC life

@InterestingSTEM Makes no sense that you would want to revert cancer cells back to cancer stem cells! This has got to be a typo & when you have such a mistake on the first sentence you have to discount the entire presentation. This is the real deal - read the paper! pmc.ncbi.nlm.nih.gov/articles/PMC10…

Japanese scientists have created a hydrogel that reverts cancer cells back to cancer stem cells in 24 hours

@Bdfr65 That $17 mil financing should get them to a viable endpoint then its up to investors to chew through the warrant overhang. The results should be excellent but aren't you surprised the stock didn't breakdown super hard. There is some underlying strength.

@MikeSheikh2 CYDY?

Looking at my largest holding. I shake my head thinking. . . . Anyone else feel the same way? Guess the ticker

@emPatheticTurtl otcmarkets.com/filing/html?id…

@buffalofireside otcmarkets.com/filing/html?id…

@MikeSheikh2 BIXT? 😆 🤣 😂

@nehoray216484 Y

@MikeSheikh2 Any updates from the last meeting, boss?

@StockBullPicks That wasn't the ticker - I gotta get ready for a conference tomorrow.

@MikeSheikh2 Well mine is $MAJI

@Capricor Although $CAPR has a cell therapy I think the the visibility of an approval will put a spotlight on the core #exosome technology.

Today we announced that the U.S. FDA has resumed review of our BLA for Deramiocel for the treatment of Duchenne muscular dystrophy and set a PDUFA target action date of August 22, 2026. Click here to read the announcement: bit.ly/4bz2qk2 #DMD #Deramiocel $CAPR

Our pledge to shareholders: No "blown out" share structure. We’re using a targeted Reg A to launch products, then closing it. Once funded, we plan to use our LMMY holdings and cash flow for a Share Buyback Program to neutralize any offering dilution. $MAJI

No mystery where the selling is from but $1.2 mil market cap defies logic. The question isn't who is selling - it doesnt matter. The question is why you aren't buying hand over fist. Y'all need to step up. EOM